Skip to content

Clinical trials

Phase 2/3 Neoplasm Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2/3 Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20031
20041
20073
20081
20091
20111
20124
20142
20153
20163
20173
20183
20194
20213
20231
20242
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status8
Active, not recruiting8
Recruiting8
Terminated6
Not yet recruiting4
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Federation Francophone de Cancerologie Digestive2
NeuroVita Clinic2
Sanofi2
The Netherlands Cancer Institute2
Affidea Nu-med Center of Oncological DIagnostics and Therapy1
Amsterdam UMC, location VUmc1
Associació per a la Recerca Oncologica, Spain1
Bellus Health Inc. - a GSK company1
BioNTech SE1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis50
Recurrence8
Colorectal Neoplasms6
Neoplasms6
Pancreatic Neoplasms5
Breast Neoplasms4
Lung Neoplasms3
Melanoma3
Prostatic Neoplasms3
Squamous Cell Carcinoma of Head and Neck3

Trials

Showing 51 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.